XBiotech, Inc.
(NASDAQ : XBIT)

( )
XBIT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.36%75.850.0%$2532.48m
NVAXNovavax, Inc. 0.15%143.31102.0%$1063.88m
AMGNAmgen, Inc. 0.55%246.021.3%$540.62m
GILDGilead Sciences, Inc. 0.00%69.531.0%$512.08m
REGNRegeneron Pharmaceuticals, Inc. 0.10%632.072.5%$472.47m
BNTXBioNTech SE 0.94%82.880.0%$427.49m
VRTXVertex Pharmaceuticals, Inc. 1.00%274.711.9%$377.02m
VXRTVaxart, Inc. -0.43%9.350.0%$327.55m
BIIBBiogen, Inc. 0.31%275.551.6%$326.98m
ILMNIllumina, Inc. -0.04%382.013.5%$309.07m
SRNESorrento Therapeutics, Inc. 4.82%9.351.8%$243.25m
IBIOiBio, Inc. 5.15%4.700.3%$202.53m
SGENSeattle Genetics, Inc. -2.85%166.276.1%$177.58m
ACHVAchieve Life Sciences, Inc. -4.62%13.000.0%$171.45m
ALXNAlexion Pharmaceuticals, Inc. -2.21%102.492.0%$170.48m

Company Profile

XBiotech, Inc. is a biopharmaceutical company. The firm engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.